BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 4, 2016
View Archived Issues
Avacta enters research collaboration with Memorial Sloan Kettering Cancer Center
Read More
NIH funding to support Qrono's development of QARRUS platform
Read More
Nitto Denko initiates phase I trials in Japan for sublingual seasonal influenza HA vaccine
Read More
Celgene offers overview of third quarter 2016
Read More
[177-Lu]Pentixather-based endoradiotherapy in xenograft models of leukemia
Read More
Umecrine Cognition reports phase I results on GR-3027
Read More
Researchers present phase II data for maribavir for treatment of cytomegalovirus infections
Read More
Aclaris Therapeutics submits IND to begin study of ATI-50001
Read More
Rebiotix's RBX-2660 effective in phase IIb trial for recurrent Clostridium difficile infection
Read More
AbbVie presents key events from the third quarter 2016
Read More
Intravenous zanamivir shows potential for severe influenza in pediatric patients
Read More
ProMIS identifies five antibody candidates with desired target profile for Alzheimer's
Read More
Albireo and Biodel complete share exchange to form combined company
Read More
KemPharm appeals FDA's CRL for Apadaz
Read More
Immunovaccine's DepoVax-formulated neoepitopes show promise in preclinical studies
Read More
ReVance Therapeutics initiates phase II trial of RT-002 in plantar fasciitis
Read More
Astellas Pharma recaps key events of second quarter of fiscal 2016
Read More
Actelion obtains exclusive option to in-license vamorolone
Read More
Bio-Path Holdings' BP-1001 awarded orphan drug status from EMA
Read More
Prana offers regulatory update on PBT-2 for Huntington's disease
Read More
ARTES Biotechnology and BioSun Pharmed collaborate on HPV vaccine in Iran
Read More
Takeda offers pipeline update for second quarter of fiscal 2016
Read More
Immunocytokine cergutuzumab amunaleukin accumulation evaluated with PET in phase I study
Read More
Galapagos describes novel GPR84 antagonists
Read More
Innocoll updates progress of Cogenzia, Xaracoll and Collaguard programs
Read More
Nordic Nanovector announces progress of phase I/II trial of Betalutin
Read More
FORMA Therapeutics discovers new histone deacetylase inhibitors
Read More
Committee recommends continuation of Atox Bio's phase III ACCUTE study
Read More
Merck KGaA presents novel activin receptor-like kinase inhibitors
Read More
